Clinical trial
Prevention of Kidney Transplant Rejection
NCT00005010 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00005010 |
|---|---|
| Title | Prevention of Kidney Transplant Rejection |
| Official title | An Interventional Trial in Established Chronic Renal Allograft Rejection |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | End-Stage Renal Disease, Chronic Allograft Nephropathy |
| Intervention type | Drug |
| Interventions | Irbesartan, Pravastatin |
| Completion | Mar 1, 2004 |
| First posted | Aug 31, 2001 |
| Last update posted | Jan 25, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: